Frontiers | Expression of MICA in Zero Hour Biopsies Predicts Graft Survival After Liver Transplantation frontiersin.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from frontiersin.org Daily Mail and Mail on Sunday newspapers.
Mitotherapeutix Awarded $2.2 Million SBIR Grant from the National Institutes of Health for siRNA NASH Candidates
Share Article FARMINGTON, Conn. (PRWEB) June 04, 2021
Mitotherapeutix LLC (MITO), a pre-clinical stage company focused on siRNA drug discovery and development based on suppression of the mitochondrial regulator MCJ (DnaJC15), today announced that it has been awarded a multi-year $2.2 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health. MITO will deploy the funds to continue IND enabling activities for siRNA candidates intended to be a novel treatment for Nonalcoholic Steatohepatitis (NASH).
“NASH remains a significant unmet medical need affecting up to 5% of all adults in the United States, according to the Liver Foundation,” said Jack Talley, Chief Executive Officer, MITO. “Our novel GalNAc conjugated-siRNA candidates are being advanced towards IND fili
What to Eat for Fatty Liver Disease, From a Registered Dietician koolam.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koolam.com Daily Mail and Mail on Sunday newspapers.